Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis

被引：0

作者：

Kulkarni, Amit A. ^{[1
]}

Hennessy, Cassandra ^{[2
]}

Wilson, Grace ^{[1
]}

Ramesh, Vidhyalakshmi ^{[1
]}

Hwang, Clara ^{[3
]}

Awosika, Joy ^{[4
]}

Bakouny, Ziad ^{[5
]}

Khan, Hina ^{[6
]}

Vilar-Compte, Diana ^{[7
]}

McKay, Rana ^{[8
]}

Jani, Chinmay ^{[8
,9
]}

Weissmann, Lisa ^{[8
,9
]}

Griffiths, Elizabeth ^{[9
,10
]}

Batist, Gerald ^{[10
,11
]}

Bouganim, Nathaniel ^{[10
,11
]}

Mavromatis, Blanche ^{[12
]}

Bashir, Babar ^{[13
]}

Nguyen, Ryan H. ^{[14
]}

Riess, Jonathan W. ^{[15
]}

Puc, Matthew ^{[16
]}

Kasi, Anup ^{[17
]}

Berg, Stephanie ^{[18
]}

Castillo, Dan Ran ^{[19
]}

Hayes-Lattin, Brandon ^{[20
]}

Hosmer, Wylie ^{[21
]}

Flora, Daniel ^{[22
]}

Mishra, Sanjay ^{[5
,6
]}

French, Benjamin ^{[1
,2
]}

Warner, Jeremy L. ^{[5
,6
]}

Lopes, Gilberto ^{[23
]}

Peters, Solange ^{[24
]}

Florez, Narjust ^{[25
]}

机构：

[1] Univ Minnesota, Minneapolis, MN USA

[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[3] Henry Ford Hlth Syst, Detroit, MI USA

[4] Univ Cincinnati, Cincinnati, OH USA

[5] Dana Farber Canc Inst, Boston, MA USA

[6] Brown Univ, Legorreta Canc Ctr, Providence, RI USA

[7] Inst Nacl Cancerol, Mexico City, Mexico

[8] Univ Calif San Diego, San Diego, CA USA

[9] Mt Auburn Hosp, Cambridge, MA USA

[10] Rosewell Pk Comprehens Canc Ctr, Buffalo, NY USA

[11] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ, Canada

[12] UPMC Western Maryland, Cumberland, MD USA

[13] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA USA

[14] Univ Illinois Hosp & Hlth Sci Syst, Chicago, IL USA

[15] Univ Calif Davis, Comprehens Canc Ctr, Sacramento, CA USA

[16] Virtua Hlth, Marlton, NJ USA

[17] Univ Kansas, Kansas City, KS USA

[18] Loyola Univ, Chicago, IL USA

[19] Loma Linda Univ, Loma Linda, CA USA

[20] Oregon Hlth & Sci Univ, Portland, OR USA

[21] Hartford HealthCare Canc Inst, Southington, CT USA

[22] St Elizabeth Healthcare, Edgewood, KY USA

[23] Univ Miami, Miami, FL USA

[24] Ctr Hosp Univ Vaudois CHUV, Lausanne, Switzerland

[25] Dana Farber Brigham Canc Ctr, Boston, MA USA

来源：

CLINICAL LUNG CANCER | 2024年 / 25卷 / 05期

关键词：

Chemotherapy; Immunotherapy; Targeted therapy; Thoracic Cancers; LUNG-CANCER;

D O I：

10.1016/j.cllc.2024.04.003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Patients with thoracic cancers and COVID-19 have high mortality and morbidity. • Systematic data evaluating the impact of recent anti-cancer therapies on COVID-19 outcomes in patients with thoracic cancers are limited. • We analyzed clinical data from patients with thoracic cancers and COVID-19 (N=927) to systematically evaluate the impact of recent anti-cancer therapies on the clinical outcomes of COVID-19 from the COVID-19 and Cancer Consortium (CCC19). • As opposed to immunotherapy or targeted therapy, recent (<3 months prior to COVID-19 diagnosis) cytotoxic chemotherapy exposure was significantly associated with COVID-19 severity. • None of the other systemic therapies or treatment modalities were significantly associated with 30-day all-cause mortality. • Baseline steroid use of 10 mg or more of prednisone equivalent was not associated COVID-19 severity and 30-day all-cause mortality. © 2024 Elsevier Inc.

引用

下载

页码：e229 / e237.e7

页数：16

共 50 条

[21] Defining COVID-19 outcomes in thoracic cancer patients: TERAVOLT (Thoracic cancERs international coVid 19 cOLlaboraTion)
Baena Espinar, J.
Torri, V.
Whisenant, J.
Hirsch, F. R.
Rogado, J.
de Castro Carpeno, J.
Halmos, B.
Ceresoli, G. L.
Gomez Rueda, A.
Tiseo, M.
Felip, E.
Majem Tarruella, M.
Monnet, I.
Tapan, U.
Wakelee, H.
Huang, L-C.
Garassino, M. C.
Peters, S.
Horn, L.
Hellmann, M.
ANNALS OF ONCOLOGY, 2020, 31 : S1204 - S1205
[22] Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: A CCC19 registry analysis
Wise-Draper, T. M.
Desai, A.
Elkrief, A.
Rini, B. I.
Flora, D. B.
Bowles, D. W.
Shah, D.
Rivera, D.
Johnson, D. B.
Lopes, G.
Grivas, P.
Thompson, M. A.
Peters, S.
Kuderer, N. M.
Nock, N. L.
Grover, P.
Li, X.
Gulati, S.
Choueiri, T. K.
Warner, J.
ANNALS OF ONCOLOGY, 2020, 31 : S1201 - S1202
[23] A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance
CANCER CELL, 2020, 38 (06) : 761 - 766
[24] COVID-19 in patients with thoracic cancers: TERAVOLT
不详
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (SUPPL 3) : S84 - S84
[25] COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study
Crolley, Valerie E.
Hanna, Daire
Joharatnam-Hogan, Nalinie
Chopra, Neha
Bamac, Ekin
Desai, Meera
Lam, Yuk-Chun
Dipro, Sabiq
Kanani, Ruhi
Benson, Jack
Wilson, William
Fox, Thomas A.
Shiu, Kai-Keen
Forster, Martin
Bridgewater, John
Hochhauser, Daniel
Khan, Khurum
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
[26] Characteristics and outcomes of SARS-CoV-2 infection in patients with invasive breast cancer (BC) from the COVID-19 and cancer consortium (CCC19) cohort study
Khaki, Ali Raza
Shah, Dimpy P.
Lustberg, Maryam B.
Accordino, Melissa K.
Stover, Daniel G.
Nagaraj, Gayathri
Rivera, Donna R.
Perez, Edith A.
Tolaney, Sara M.
Peppercorn, Jeffrey
Grivas, Petros
Warner, Jeremy L.
Painter, Corrie A.
Lopes, Gilberto de Lima, Jr.
Peters, Solange
Thompson, Michael A.
Choueiri, Toni K.
Rini, Brian I.
Lyman, Gary H.
Kuderer, Nicole M.
Vinayak, Shaveta
CANCER RESEARCH, 2021, 81 (04)
[27] COVID-19 mortality in hospitalized cancer patients is not significantly affected by chemotherapy or other anti-cancer treatments
Lee, L.
Starkey, T.
Cazier, J-B.
Kerr, R.
Middleton, G.
ANNALS OF ONCOLOGY, 2020, 31 : S994 - S995
[28] Effect of Bacillus Calmette-Guerin (BCG) exposure on severity of COVID-19 infection: A COVID-19 and Cancer Consortium (CCC19) study.
Schmidt, Andrew Lachlan
Bakouny, Ziad
Labaki, Chris
Bashir, Babar
Clement, Jessica M.
Edwin, Natasha Catherine
Flora, Daniel Blake
Girard, Jennifer
Gulati, Shuchi
Hwang, Clara
Jani, Chinmay
Lopes, Gilberto
Mesa, Ruben A.
Redelman-Sidi, Gil
Mishra, Sanjay
Warner, Jeremy Lyle
Choueiri, Toni K.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[29] Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19)
Grivas, P.
Warner, J.
Shyr, Y.
Shah, D.
Rubinstein, S. M.
Kuderer, N. M.
Choueiri, T. K.
Rivera, D.
Painter, C.
Thompson, M. A.
Peters, S.
Desai, A.
Khaki, A. R.
Pennell, N. A.
Hawley, J.
Halmos, B.
Puc, M. M.
Lyman, G. H.
Rini, B. I.
Lopes, G.
ANNALS OF ONCOLOGY, 2020, 31 : S1202 - S1203
[30] Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments
Jafari, Anya
Dadkhahfar, Sahar
Perseh, Sahra
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 151

← 1 2 3 4 5 →